Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000896065 | SCV001040139 | likely benign | not provided | 2025-01-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003259010 | SCV003975690 | uncertain significance | Inborn genetic diseases | 2023-04-25 | criteria provided, single submitter | clinical testing | The c.10238G>A (p.R3413H) alteration is located in exon 74 (coding exon 74) of the LAMA5 gene. This alteration results from a G to A substitution at nucleotide position 10238, causing the arginine (R) at amino acid position 3413 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003958042 | SCV004767620 | likely benign | LAMA5-related disorder | 2023-04-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |